Investor Relations

OPKO Health Announces Leadership Changes at BioReference Laboratories more »

OPKO'S GeneDx Announces Research Collaboration with Radboud University Medical Center more »

OPKO Health Enrolls First Patient in Phase 2B Study of OPK88004 to Treat Benign Prostatic Hypertrophy more »

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results more »

SEC Filings

  
Filing Description Date Filed Size Sorted Ascending View  
REGDEX form regdex Feb 21, 2007 0.0 KB View HTML  
REGDEX form regdex Apr 16, 2007 0.0 KB View HTML  
EFFECT effectiveness order Nov 28, 2011 0.0 KB View HTML  
RW request for withdrawal Nov 27, 2002 22.3 KB View HTML View PDF  
3 martin gordon f Nov 12, 2003 27.4 KB View HTML View PDF View XLS  
3 huntz john j jr Dec 18, 2003 27.6 KB View HTML View PDF View XLS  
3 paganelli john a Dec 19, 2003 27.7 KB View HTML View PDF View XLS  
424B3 prospectus filed pursuant to rule 424 Nov 16, 2000 22.6 KB View HTML View PDF  
3 benou robert s Dec 15, 2003 27.5 KB View HTML View PDF View XLS  
3 rubin melvin l md Apr 6, 2007 19.2 KB View HTML View PDF View XLS  
3 lerner richard a Apr 6, 2007 19.2 KB View HTML View PDF View XLS  
3 kolosov dmitry Jun 15, 2012 20.7 KB View HTML View PDF View XLS  
3 rodriguez juan f Jul 18, 2012 20.7 KB View HTML View PDF View XLS  
3 baron robert a Dec 17, 2003 29.0 KB View HTML View PDF View XLS  
3 opko health inc. Jul 17, 2012 20.6 KB View HTML View PDF View XLS  
3 spencer david lee Dec 17, 2003 28.9 KB View HTML View PDF View XLS  
3 pfenniger richard c jr Jan 25, 2008 21.0 KB View HTML View PDF View XLS  
3 frost group, llc Feb 13, 2007 19.1 KB View HTML View PDF View XLS  
3 shams naveed k Feb 11, 2008 21.2 KB View HTML View PDF View XLS  
8-K current report Apr 11, 2003 25.2 KB View HTML View PDF View XLS  
Showing 1-20 of 2171 Page: 1 2 3 4 5 ... 109  Next 20

Email  Sign up for email alerts